RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Pharmaceutical Industry

A collection of news and information related to Pharmaceutical Industry published by this site and its partners.

Top Pharmaceutical Industry Articles

Displaying items 78-88
  • Allergan is in merger talks with Irish pharmaceutical firm Actavis

    Allergan is in merger talks with Irish pharmaceutical firm Actavis
    Botox maker Allergan Inc. of Irvine, which has spent six months fighting a hostile takeover attempt by a Canadian company, is in increasingly serious discussions to merge with Irish pharmaceutical firm Actavis. If Allergan agrees to be acquired by...
  • Hospira gets warning from FDA over drug manufacturing violations

    Hospira gets warning from FDA over drug manufacturing violations
    Hospira said Wednesday it received a warning letter from the Food and Drug Administration after an inspection of its Australian manufacturing facility this year identified "significant violations" of drug manufacturing practices. The warning was...
  • Allergan says a 2nd suitor wants to buy it, adding to takeover drama

    Allergan says a 2nd suitor wants to buy it, adding to takeover drama
    Botox maker Allergan Inc., which has been fighting an unsolicited takeover bid from a Canadian pharmaceutical maker for six months, said in a regulatory filing that a second company is interested in buying it. Allergan did not identify the new...
  • Oklahoma Supreme Court puts abortion restriction on hold

    The Oklahoma Supreme Court on Tuesday temporarily put on hold a state law restricting abortions while the issue is argued in a lower court. The unanimous action by the high court means that women in Oklahoma can continue to use the prescription drugs...
  • Allergan loses bid to block Ackman from voting on takeover

    Allergan loses bid to block Ackman from voting on takeover
    Botox maker Allergan Inc. lost its bid to prohibit activist investor Bill Ackman's hedge fund from voting in a shareholder election that could decide a hotly contested takeover effort. Allergan had accused Ackman's Pershing Square Capital Management...
  • OraSure expects milestones in its Ebola research

    OraSure expects milestones in its Ebola research
    By the end of the year, Bethlehem-based OraSure expects to announce key research milestones in determining if its OraQuick rapid in-home HIV test can be adapted to screen patients for Ebola. The company has consulted with the federal Food and Drug...
  • A balloon for obesity: an option between medication and surgery?

    A balloon for obesity: an option between medication and surgery?
    For many struggling with obesity, taking one of the newly approved prescription medications for weight loss (marketed as Qsymia, Belviq and Contrave) feels like climbing a mountain with a walking cane — it's a little help, but not enough. And...
  • Allergan, fighting off Valeant, discussing merger with another firm

    Allergan, fighting off Valeant, discussing merger with another firm
    Botox maker Allergan Inc. said it’s discussing a merger with an unnamed firm as it battles a hostile takeover by Valeant Pharmaceuticals. For six months Irvine-based Allergan has fought off an unsolicited takeover bid from Valeant...
  • Hospira profit soars despite loss of drug exclusivity

    Hospira profit soars despite loss of drug exclusivity
    Lake Forest-based drugmaker Hospira's profit skyrocketed in the third quarter compared with the same period a year earlier, mainly because of the sale of its clinical surveillance software business, Theradoc. Net income rose to $158.6 million, or 92...
  • Activist investor Bill Ackman wants auction for Allergan

    Activist investor Bill Ackman wants auction for Allergan
    Activist hedge fund manager Bill Ackman on Friday urged Botox maker Allergan Inc. to put itself up for auction. The request follows Allergan’s disclosure that it is in talks to potentially merge with a firm other than the Canadian company Ackman...
  • Salix Pharmaceuticals drops tax inversion deal amid backlash

    Salix Pharmaceuticals drops tax inversion deal amid backlash
    Salix Pharmaceuticals called off its merger with a foreign drug maker Friday, citing the political backlash against tax inversion deals. The deals—in which a company reincorporates abroad to gain lower taxes—drew fire this summer after...